Participants 55 84 3
experimental human influenza:
Participants 519 575 4
treatment of influenza in experimentally infected humans
Participants 710 747 3
2 large US university medical schools
Participants 762 918 6
A total of 117 healthy adult volunteers (aged 18-40 years; median age, 21 years) who were susceptible (hemagglutination-inhibition antibody titer < or =1:8)
